AC Immune Is An Alzheimer's Pure Play With A Lot On The Line
October 18, 2016 at 11:15 AM EDT
Credit Suisse initiated coverage of AC Immune Ltd (NASDAQ: ACIU) with an Outperform rating and an $18 price target. Alzheimer's Pure ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.